Showing results (101-110 of 114) with videos related to
Sort By:
Pageof 12
Diabetes Research and Clinical Practice|February 27, 2022
Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial)Piero Ruggenenti, Monica Cortinovis, Matias Trillini, et al.The New England Journal of Medicine|November 2, 2004
Preventing microalbuminuria in type 2 diabetesPiero Ruggenenti, Anna Fassi, Anelja Parvanova Ilieva, et al.Clinical Neurology and Neurosurgery|July 30, 2024
Acute kidney injury is associated with soluble vascular cell adhesion molecule 1 levels and short-term mortality in patients with ischemic strokeMarcel Jaqueto, Daniela Frizon Alfieri, Maria Caroline Martins de Araújo, et al.The Lancet. Diabetes & Endocrinology|November 7, 2017
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trialAneliya Parvanova, Matias Trillini, Manuel A Podestà, et al.Journal of Hypertension|December 10, 2021
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patientsMauro Gori, Carlo Berzuini, Emilia D'Elia, et al.Cardiovascular Diabetology|August 10, 2023
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitusAlessandro Mantovani, Mario Luca Morieri, Luisa Palmisano, et al.Diabetes & Metabolism|November 22, 2023
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitusAlessandro Mantovani, Mario Luca Morieri, Raffaella Aldigeri, et al.Diabetes & Metabolism|September 14, 2023
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitusAlessandro Csermely, Alessandro Mantovani, Mario Luca Morieri, et al.Plos Medicine|July 14, 2021
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) studyPiero Ruggenenti, Monica Cortinovis, Aneliya Parvanova, et al.The Journal of Clinical Endocrinology and Metabolism|March 7, 2023
Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 DiabetesAlessandra Dei Cas, Raffaella Aldigeri, Alessandro Mantovani, et al.Pageof 12